On ECHEMI
Home > Drugs > Meibomian gland carcinoma
Meibomian gland carcinoma
Meibomian gland carcinoma is a malignant tumor originating from the sebaceous glands. It has a high incidence rate and ranks second among eyelid malignancies. In terms of gender, it is more common in females than in males. In terms of the site of onset, it is more common in the lower eyelid than in the upper eyelid. Its malignancy varies greatly according to its classification. Those with low malignancy develop slowly over many years, while those with high malignancy develop quickly and cause early metastasis. Therefore, those over 40 years old with recurrent chalazion-like lesions should pay attention.
  • Site of disease:

    Eye
  • Infectious :

    Not contagious
  • Frequent population:

    The age of onset is mostly between 50 and 70 years old, and female...
  • Related symptoms:

    Yellow nodules subcutaneous nodules nodules ulcers
  • Concurrent disease:

Related Drugs
Berbamine Hydrochloride Tablets
Indication: It is used for leukopenia caused by various reasons. It can also be used to prevent leukopenia after cancer radiotherapy and chemotherapy.
Berbamine Hydrochloride Tablets
Indication: It is used for leukopenia caused by various reasons. It can also be used to prevent leukopenia after cancer radiotherapy and chemotherapy.
Guyuan Capsule
Manufacturer:

Zhejiang Wecome Pharmaceutical Company Limited

Guyuan Granules
Manufacturer:

Jilin Aodong Pharmaceutical Industry Group Yanji Co., Ltd.

Aiyu Capsules
Manufacturer:

Guizhou Yibai Women's Pharmacy Co., Ltd.

Related Ingredients
  • 2-(CHLOROMETHYL)-4-(4-NITROPHENYL)-1,3-THIAZOLE list

    89250-26-0
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.